Peter Stephens | Sunday, 9th February, 2020 | More on: ^FTSE Investing £100 per week and ending up with a seven-figure portfolio may sound like a pipe dream to most people. However, it could be a much more attainable goal than it first seems due to the long-term growth potential of the FTSE 100.By investing in a range of large-cap shares, holding them over the long run and reinvesting your dividends, you could end up with a £1m+ portfolio. By contrast, investing in a Cash ISA or savings account may mean that you experience disappointing returns that fail to improve your long-term financial situation.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…FTSE 100 potentialThe FTSE 100’s total annual returns since its inception 36 years ago have been around 9%. Assuming a similar rate of growth in future, a £100 investment in the index could be worth over £1m over a 34-year period. This assumes that dividends are reinvested, and that no capital is withdrawn from your portfolio.With the FTSE 100 currently appearing to offer good value for money, its future returns could prove to be relatively impressive. For example, it has a dividend yield of 4.4%, which is above its long-term average, while major sectors such as resources, energy and financial services appear to offer many stocks that trade on low ratings compared to their historic averages. Over the long run, those valuations may revert towards their averages, which may lead to higher returns for investors in the FTSE 100.Cash prospectsWhile the FTSE 100 could catalyse your portfolio’s performance, holding cash or investing in a Cash ISA may not. At the present time, savers may struggle to obtain an income return above 1.5%. Assuming such a rate of return over the same 34-year period discussed above, paying £100 per week into a savings account would lead to a total balance of £228,000.Clearly, there is scope for interest rates to rise over the coming decades. But history shows that cash returns have lagged the stock market’s returns, due to the lower risk of cash, which may mean that a higher regular investment than £100 per week is required to generate a £1m+ portfolio.Risk/rewardWhile the FTSE 100 is a riskier place to invest compared to cash, investors with a long-term outlook are likely to have sufficient time to enable their short-term paper losses to recover. This could mean that, while holding a modest amount of cash for emergencies is a sound move, focusing your capital on the FTSE 100 is a better idea when it comes to improving your long-term financial situation.Of course, buying high-quality shares while they trade at low prices could enable you to beat the FTSE 100 and generate even higher returns. This could shorten the amount of time it takes to produce a £1m+ portfolio, and may lead to greater financial freedom in older age. Enter Your Email Address Simply click below to discover how you can take advantage of this. I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. Stop saving and start investing! How the FTSE 100 could turn £100 per week into a £1m ISA Image source: Getty Images Our 6 ‘Best Buys Now’ Shares Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. “This Stock Could Be Like Buying Amazon in 1997” Peter Stephens has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. See all posts by Peter Stephens
Charities Aid Foundation (CAF) has launched a text donation service designed to make it “easy and affordable for all charities” to fundraise and communicate with supporters through their mobile phones. The new service, part of CAF’s Fundraising Support Service, has been established in partnership with Vir2 Ltd, the specialist provider of mobile fundraising solutions to the not for profit sector.CAF has set up two charity shortcodes to collect £3 and £5 donations on behalf of charity clients. CAF will set up campaign keywords, collect payments from the moblie phone networks and claim Gift Aid on behalf of charities.John Low, Chief Executive of the Charities Aid Foundation announced the new service saying; “Donating by text is easy, quick and simple for both donors and charities. We have seen substantial growth in donating by text with Comic Relief raising £7.8milllion this way in 2009.Roger Craven, Managing Director of Vir2 Ltd, which has run over 1,000 campaigns and works with 25% of the top UK charities, said: “It is important that more charities can utilise mobile phone technology especially as the delivery of social networking, entertainment and payment are converging on the mobile phone. I know at first hand the growth in demand from charities for text services and how successful text campaigns are proving. It is key to the future of fundraising and helps charities reach new audiences.”CAF will charge charities £20 per month for each keyword used and a small fee (2.5%) for every donation.www.cafonline.org/text AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis Charities Aid Foundation launches text donation service Tagged with: Charities Aid Foundation Digital mobile mobile phones 52 total views, 1 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis Howard Lake | 23 November 2010 | News About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of GoodJobs.org.uk. Researching massive growth in giving.
Melanie May | 4 May 2017 | News About Melanie May Melanie May is a journalist and copywriter specialising in writing both for and about the charity and marketing services sectors since 2001. She can be reached via www.thepurplepim.com. Tagged with: higher education Research / statistics “Philanthropic giving is now at the heart of UK university culture. University fundraising is dependent upon building long-term relationships with donors, and their investment over time demonstrates a powerful belief in the capacity of universities to tackle world problems. It’s particularly pleasing to see that our alumni make such a major contribution. It’s clear that they, more than anyone, have experienced the benefits of university study and it’s gratifying that they want to give back.” 214 total views, 2 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis20 Philanthropic income to UK universities rose a record-breaking 23%, reaching over £1bn for the first time last year.The annual Ross-CASE Survey of Charitable Giving to Universities reported the increase across 110 participating UK universities.While the value of donations rose, a slight decrease of 0.5 percent was seen in the overall number of donors year on year, with a significant proportion of the new funds secured from large gifts and pledges. The total amount gifted from legacies was £104.7 million from 1,179 legacy donors.Alumni donors (177,798) accounted for 80 percent of individual donors (223,256). As in previous years of the 15-year research project, new funds secured from alumni (£322m) account for significantly more than non-alumni individuals (£149m) while new funds secured from trusts and foundations (£442m) far outweigh companies (£82m).Comparing the survey data for 2015-16 to the previous year, findings show that investment in fundraising and alumni relations reported an increase of 16 percent and 10 percent, respectively. The report also shows a 27 percent increase in the number of donors pledging gifts worth £500,000 or more, up from 189 to 240.The report was compiled by the Council for Advancement and Support of Education and also reveals where funds were spent. This included supporting the development and recent rollout of a genetic test to improve childhood cancer treatment at The Institute of Cancer Research, supporting dementia research at the University of Edinburgh and restoring the McEwan Hall in Edinburgh.Other projects include funding new scholarships to enable Londoners from disadvantaged backgrounds to study at the University of London and supporting talented students from Rwanda, Tanzania and Uganda to study for a master’s degree at the University of Manchester in subjects that aren’t available in their home country.Sue Cunningham, CASE president and CEO said:“Surpassing 1 billion pounds is a testament to the hard work of more than 2,100 fundraising and alumni relations professionals, the academic institutions they support and the philanthropic donors who believe in investing in the important work of universities. These dedicated professionals are advancing education in profound ways and transforming lives and society in the process.”Tricia King, vice president, global engagement at CASE, said: Advertisement 213 total views, 1 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis20 Donations to UK universities rise above £1bn for first time
Home Local News Business DAILY OIL PRICE: April 19 Pinterest Twitter WhatsApp Pinterest Previous articlePermian Playhouse debuts new show Friday nightNext articleOne suspect charged in purchase order scam admin RELATED ARTICLESMORE FROM AUTHOR Local NewsBusiness DAILY OIL PRICE: April 19 Facebook Snap Inc. to Participate in the Morgan Stanley Technology, Media & Telecom Conference 2021 Foolproof Roasted Pork TenderloinVirgin Coco MojitoSummer Spaghetti SaladPowered By 10 Sec Mama’s Deviled Eggs NextStay Twitter Octopus Energy U.S. to Discount Customers’ Bills by as Much as 90% WhatsApp Facebook Crude Oil: 68.29 (-.18)Nymex MTD AVG: 65.2126.Natural Gas: 2.66 (-.079).Gasoline: 2.0774 (+0.0091).Spreads: May/June (+.04) June/July (+.25).Plains WTI Posting: 64.75 (-.25). By admin – April 19, 2018 Congressman Mike Conaway talks to the Odessa American on Jan. 7, 2018. Rattler Midstream: 4Q Earnings Snapshot
Sonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn® Disinfecting Solution is Now Available in Hong Kong and Thailand By Digital AIM Web Support – January 28, 2021 TAGS Twitter WhatsApp Pinterest Facebook Previous articleAt Sundance, pandemic dramas unfold on screen and offNext articleDermTech Featured in Melanoma Research Foundation Weekly “Ask the Expert” Facebook Live Events Alongside Notable Industry Scientists Digital AIM Web Support WhatsApp Facebook WOODSTOCK, Ga.–(BUSINESS WIRE)–Jan 28, 2021– Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, disinfectant use and dermatological conditions, and Microderm Technologies Ltd. announce that Dermodacyn® disinfectant has received import clearance as a medical device for Thailand with the help from Microderm’s partner VetSynova Co. Ltd., Thailand, and is now available online and in pharmacies and stores in Hong Kong and Thailand. Dermodacyn disinfecting solution is designed to be sprayed as an aerosol to disinfect areas suspected to contain bacteria and viruses that can lead to disease. Dermodacyn disinfectant is medical grade and can be used in hospitals to keep doctors and patients protected and safe. It also performs well in other high traffic areas that require constant cleaning and disinfecting. In a study by the University of Hong Kong and Queen Mary Hospital Dermodacyn disinfecting solution showed it effectively kills the coronavirus SARS-CoV-2. See https://www.journalofhospitalinfection.com/article/S0195-6701(20)30339-X/fulltext. “We believe the fact that Dermodacyn® can outperform other products to kill viruses and bacteria effectively and at the same time be completely safe to be used on humans will boost customer confidence and help us further expand our customer base into the public service industry,” said Mr. Christopher Lee, Founder and CEO of Microderm Technologies. “We originally brought Dermodacyn® to customers in Hong Kong and other parts of Asia as a skin antiseptic and wound treatment product before introducing it as a surface disinfectant. This may be the only product to be applied first on humans before being used as a surface disinfectant. This is why Dermodacyn disinfectant is one of the safest and most effective products of its kind in the market. The well-being of our customers is always our priority,” Mr. Lee added. “Sonoma’s Microcyn technology-based products have been safely and effectively used for over 20 years. We are proud to work with partners like Microderm who are showcasing our technology through consumer channels and highly regarded research institutions,” said Amy Trombly, CEO of Sonoma Pharmaceuticals. “We plan on continuing to research new areas of use and plan to continue to develop new products that will help our customers around the world stay safe and healthy.” For more information and where to buy Dermodacyn visit https://www.dermodacyn.com/shop. About Sonoma Pharmaceuticals, Inc. Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at www.sonomapharma.com. For partnership opportunities, please contact [email protected] About Microderm Technologies Ltd. Microderm Technologies Ltd. is based out of Hong Kong, and its mission is to improve the quality of lives of people by minimizing the risks of infectious diseases. In collaboration with the inventors of the unique and patented Microcyn® Technology, Microderm launched a revolutionary line of wound healing products, Dermodacyn. This is the first of its kind to be launched in the Hong Kong over-the-counter market for human use. Microderm has made first class wound healing products affordable and easily accessible to every person. At Microderm, we are dedicated to providing safe, effective, and simple solutions to wound treatment that are supported by clinical studies and are internationally recognized. Forward-Looking Statements Except for historical information herein, matters set forth in this press release are forward-looking within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial and technology progress and future financial performance of Sonoma Pharmaceuticals, Inc. and its subsidiaries (the “company”). These forward-looking statements are identified by the use of words such as “continue,” “promise,” and “expand,” among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the company’s business that could cause actual results to vary, including such risks resulting from the global COVID-19 pandemic, that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by the company’s patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for the company’s products will not be as large as expected, the company’s products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company’s cash needs, fund further development and clinical studies, as well as uncertainties relative to varying product formulations and a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in the company’s filings with the Securities and Exchange Commission. The company disclaims any obligation to update these forward-looking statements, except as required by law. Sonoma Pharmaceuticals™ and Microcyn® are trademarks or registered trademarks of Sonoma Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners. View source version on businesswire.com:https://www.businesswire.com/news/home/20210128006101/en/ CONTACT: Media and Investor Contact: Sonoma Pharmaceuticals, Inc. [email protected] KEYWORD: GEORGIA NORTH AMERICA UNITED STATES ASIA PACIFIC THAILAND HONG KONG INDUSTRY KEYWORD: HEALTH OTHER HEALTH SURGERY OPTICAL OTHER SCIENCE PRACTICE MANAGEMENT RESEARCH MANAGED CARE INFECTIOUS DISEASES GENERAL HEALTH HOSPITALS SCIENCE NURSING MEDICAL SUPPLIES SOURCE: Sonoma Pharmaceuticals, Inc. Copyright Business Wire 2021. PUB: 01/28/2021 04:30 PM/DISC: 01/28/2021 04:30 PM http://www.businesswire.com/news/home/20210128006101/en Local NewsBusiness Pinterest Twitter
Magdalen College have paid tribute to an 80-year-old former professor of the college who has reportedly been trampled to death by a herd of cows in a field near a village church.Professor Brian Bellhouse was named as the victim of the incident in Guestling, near Hastings, East Sussex. He is said to have been walking in the field, before a herd of cows became agitated and charged.Police, paramedics and air ambulance crews were unable to save his life, and he was pronounced dead at the scene on Monday morning.A Sussex Police spokesman said the death was not being treated as suspicious and had been passed to the coroner’s office.“An 80-year-old man died after being found trampled in a field of cattle at Church Lane, Guestling, on Monday 12 June,” said the spokesman.“Police and paramedics performed CPR after being called at 11.02am and an air ambulance landed at the scene, but he was sadly pronounced dead at 11.46am.”Magdalen College, to which Bellhouse came to read Maths in 1957, paid tribute to his time at the University.“The college is very sad to announce that Professor Brian Bellhouse has passed away at the age of 80,” a spokesman said.“He obtained his DPhil in Engineering Science in 1964 and was then made a Fellow by Examination. He was elected an Official Fellow in Engineering Science in 1966. On his retirement in 2004 he was elected an Emeritus Fellow.“Brian co-founded the company PowderJect in 1993 which became one of the first companies to be spun-out successfully from the University of Oxford and was based at our Oxford Science Park.“Brian was a major donor to the college and endowed the Oxford-Bellhouse Graduate Scholarship at Magdalen in biomedical engineering.”
Puff pastry supplier Jus-Rol has launched ’Shape It Up’, whereby bakers can source ideas and recipes using Jus-Rol’s three different pastry shapes – oval, round and square. Jus-Rol’s Puff Pastry Shapes are pre-rolled, cut to size and defrost in a few minutes. Recipes include Cheese, Tomato & Bacon Wraps, Chicken Spinach & Red Pepper Open Tarts and Goat’s Cheese & Aubergine Windmills.”The success of Shape It Up is based on the fact that caterers don’t necessarily have the time to make puff pastry from scratch, never mind consider different presentation styles,” said John McKears, the firm’s foodservice sales manager. “Jus-Rol’s Puff Pastry Shapes will make their dishes a real talking point with customers.”[http://www.jusrolfoodservice.co.uk]
Sign up for our COVID-19 newsletter to stay up-to-date on the latest coronavirus news throughout New York A St. James man was sentenced Friday to six years in federal prison for defrauding 74 people out of nearly $18 million after conning them into investing in his Ponzi scheme for almost a decade.James Peister had pleaded guilty to securities fraud at Central Islip federal court in November.“Peister lulled his victims into a false sense of security through empty promises of reliable growth and conservative investing,” said Kelly Currie, acting U.S. Attorney for the Eastern District of New York. “After stealing millions of dollars in inheritances and retirement savings, Peister now faces his own retirement in prison while his victims struggle to rebuild their lives.”Prosecutors said the 63-year-old scam artist assured investors that their money would be invested safely, but he instead used the money to pay millions of dollars in redemptions to prior victims to keep the scheme afloat and to afford his luxurious lifestyle between 2000 and 2009.He sent phony account statements to investors that falsely showed that their funds were performing well, and he submitted bogus financial statements to the investment fund’s independent auditor, authorities said.Peister’s Ponzi scheme collapsed in the wake of the financial crisis in 2008, when he could no longer keep up with demands for redemptions from nervous investors.He was also sentenced to three years of supervised release, ordered to pay $9.6 million in restitution to the victims and forfeited $17.9 million, including his home and his Hummer.
Valuation, entry point and market knowledge are key in strategies for investing in stocks during volatile times as COVID-19 risks will likely persist throughout the year, fund managers and brokerages have said, expecting a drop of 15 to 20 percent in benchmark stock prices this year.Lilis Setiadi, president director of major Indonesian fund manager Batavia Prosperindo Aset Manajemen, said that virus-related matters would continue to cause a lot of volatility in the country’s capital market, at least until the discovery of vaccines.“Be ready and get used to volatility in the stock market. It should be seen as an opportunity for dollar-cost averaging,” Lilis said in her presentation for The Jakarta Post’s Jakpost Up Close webinar, “Investing in stocks: Best strategies in volatile times”. During this year’s first quarter, the JCI fell 37.33 percent to a historic low of 3,937.63 on March 24, the lowest it had been since 2012. From that lowest point, the index rallied 26.67 percent to 4,987.78 at the end of Wednesday’s trading. The accumulated fall throughout the year was recorded at 20.82 percent, whereas the market gained 10 percent in the past month, indicating high volatility. “This is like a discount in the stock market,” said Irwanti, investment director of Schroders Indonesia, which had Rp 61.1 trillion in assets under management as of the end of May. “If you invest in the future, if you look far into the horizon, you shouldn’t be afraid [of short-term volatility].”The stock market still offered bigger returns in comparison to other assets, such as property, gold and time deposits, she added. For this year, Schroders did not have an official JCI target set out given the high market volatility, however Irwanti estimated a best-case scenario of the stock index losing 15 percent this year.Both Schroders and Batavia prefer large-cap stocks. Schroders was limiting exposure to high beta names, or stocks that have higher returns in bull markets and lower returns in bear markets, Irwanti said. Meanwhile, Batavia included several small and medium cap stocks with strong fundamentals and earnings projections in its portfolio, Lilis said.Hariyanto Wijaya, head of research at Mirae Asset Sekuritas Indonesia, the country’s most active brokerage house, reminded investors to keep their losses small when investing during volatile times.“Please set your cut loss limit quite reasonably, we suggest around 20 percent,” Hariyanto said during the webinar. And on the flip side, he said: “If investors already get sufficient gains, I suggest taking a profit,” as a buy-and-hold position may not always be a good investment strategy. Mirae forecast the JCI to end the year at 5,180 in a baseline scenario, reflecting a 17.8 percent drop from the previous year. The bull case is projected at 5,830 and bear case at 4,160, according to Mirae estimates.In the past month, the JCI recorded a net foreign buy of Rp 12.22 trillion, a reversal of foreign investment outflows in the past three months where the bourse recorded a total net foreign sell of Rp 5.14 trillion. Throughout the year, foreign investors have sold Rp 11.63 trillion worth of Indonesian shares. For millennial investors who are still navigating their way around the stock market, Sucor Sekuritas equity and business development director Bernadus Wijaya pointed to three styles of investing: value investing, growth investing and income investing. Value investing is when an investor tries to find stocks that are sold relatively cheaper in the market in comparison to its book value. Growth investing, as indicated by its name, is when an investment decision is determined by the stock’s strong earnings growth. In income investing, an investor looks for companies that give high dividend yield consistently. “Buy in stages. Choose good companies with good fundamentals, but we have to understand technical analysis so we know when to enter,” said Bernadus, advising first-time investors to get capital gain from their stock investments.Based on gains made between Dec. 31, 2007, and Nov. 30, 2018, the local bourse was the best-performing stock exchange for long-term investors, Bernadus said, as it gained 120.56 percent during that period, while the United States’ S&P 500 only made a gain of 87.98 percent. This year, however, the JCI was among the worst-performing markets year-to-date, despite its recent gains. When the JCI fell by almost 21 percent, Hong Kong’s Hang Seng Index dropped 14.23 percent, while Japan’s Nikkei 225 fell a modest 3.23 percent. The panelists agreed that the recent market rebound was largely driven by the reopening of economies worldwide, as well as central banks’ stimulus funds, which flow into the financial market. However, full economic recovery may largely depend on solutions to end the pandemic, with vaccines currently still being developed. Dollar-cost averaging refers to an investment strategy in which investors try to reduce the impact of market volatility by dividing their investments into multiple smaller purchases, with regular intervals in between each purchase. Aside from that, Lilis also recommended a diversification strategy amid the pandemic. Batavia, which managed Rp 44.79 trillion funds as of the end of May, projected the benchmark Jakarta Composite Index (JCI) to close the year at between 5,000 and 5,300, representing a fall of 15 to 20 percent from last year’s end point of 6,300.Steep falls in domestic stocks this year had been unprecedented, with the local stock index falling into bear market sooner than previous declines, which were more gradual, Indonesia Stock Exchange (IDX) development director Hasan Fawzi said during the webinar.“If I can give a bit of advice, the basic strategy [in volatile times] is to invest in yourself, know and understand yourself, fully understand your investment profile, risk profile and goals, skills, capacity and investment behavior. So in the end you adopt the best strategy that best fits your portfolio,” Hasan said. Topics :